All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.


An Investigation into the Effectiveness of Sacubitril and Valsartan Sodium with Percutaneous Coronary Intervention in Acute Myocardial Infarction

Author(s): Xuebo Li and Fengyi Chen*
Department of Cardiology, The 7th People’s Hospital of Zhengzhou, Zhengzhou, Henan Province 450000, China

Correspondence Address:
Fengyi Chen, Department of Cardiology, The 7th People’s Hospital of Zhengzhou, Zhengzhou, Henan Province 450000, China, E-mail:

To evaluate the effectiveness of emergency percutaneous coronary intervention when used in combination with sacubitril and valsartan sodium for managing patients with acute myocardial infarction. Our randomized controlled trial enrolled 78 patients with acute myocardial infarction treated at our hospital between October 2018 and October 2020. Participants were allocated randomly into two groups; observation group (n=39) received sacubitril and valsartan sodium combined with percutaneous coronary intervention, and the control group (n=39) received enalapril and percutaneous coronary intervention. In our study, in addition to comparing changes in cardiac biomarkers (troponin I and N-terminal pro-brain natriuretic peptide) before and after treatment, we also analyzed adverse reactions and changes in cardiac structure and function. After 6 mo, left ventricular end-diastolic diameter and left ventricular end-systolic diameter of observation group was obviously decreased, while the control group has no significant change. In the aspect of left ventricular ejection fraction, the observation group increased significantly, while the control group had no significant change. In the N-terminal pro-brain natriuretic peptide serum levels and the incidence of heart failure, the observation group showed advantages, compared with the control group. Sacubitril and valsartan sodium combined with emergency percutaneous coronary intervention can improve cardiac structural and functional indices, reduce the risk of heart failure, and increase long-term survival time in acute myocardial infarction patients. This approach is safe and effective and therefore warrants further consideration in clinical settings.

Full-Text | PDF

Google scholar citation report
Citations : 66710

Indian Journal of Pharmaceutical Sciences received 66710 citations as per google scholar report